Two new HIV drugs, Emtriva and Reyataz

August 2003

Two new HIV drugs, Emtriva and Reyataz, will help simplify drug regimens...because they're each given just ONCE a day.

Emtriva (emtricitabine) is a nucleoside analogue...similar to lamivudine (Epivir).

Emtriva is well-tolerated. It DOESN'T affect cytochrome P450 enzymes...therefore drug interactions aren't likely.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote